Cognitive Impairment in Older Patients With Breast Cancer Before Systemic Therapy: Is There an Interaction Between Cancer and Comorbidity?

Neuropsychological Outcomes of Older Breast Cancer Survivors: Cognitive Features Ten or More Years After Chemotherapy

(2014) Torricia H. Yamada et al.   JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES

The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer

(2013) K. L. Pomykala et al.   Brain Imaging and Behavior

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Null Association between Tamoxifen Use and Dementia in Danish Breast Cancer Patients

(2013) A. G. Ording et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials

(2013)   LANCET

Cognitive Effects of Cancer and Its Treatments at the Intersection of Aging: What Do We Know; What Do We Need to Know?

(2013) Jeanne S. Mandelblatt et al.   SEMINARS IN ONCOLOGY

Brief self-report measure of work-related cognitive limitations in breast cancer survivors

(2013) Alicia Ottati et al.   Journal of Cancer Survivorship

Aging, Cellular Senescence, and Cancer

(2012) Judith Campisi   Annual Review of Physiology

Biomarkers for Insulin Resistance and Inflammation and the Risk for All-Cause Dementia and Alzheimer Disease

(2012) Thomas M. van Himbergen   ARCHIVES OF NEUROLOGY

Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: A replication and extension study

(2012) Brenna C. McDonald et al.   BRAIN BEHAVIOR AND IMMUNITY

Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?

(2012) Patricia A. Ganz et al.   BRAIN BEHAVIOR AND IMMUNITY

Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors

(2012) Shelli Kesler et al.   BRAIN BEHAVIOR AND IMMUNITY

Cognitive function and breast cancer: promise and potential insights from functional brain imaging

(2012) Patricia A. Reuter-Lorenz et al.   BREAST CANCER RESEARCH AND TREATMENT

Prechemotherapy differences in response inhibition in breast cancer patients compared to controls: A functional magnetic resonance imaging study

(2012) Carole Scherling et al.   JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY

Neuropsychological Performance in Survivors of Breast Cancer More Than 20 Years After Adjuvant Chemotherapy

(2012) Vincent Koppelmans et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer- and Cancer Treatment–Associated Cognitive Change: An Update on the State of the Science

(2012) Tim A. Ahles et al.   JOURNAL OF CLINICAL ONCOLOGY

Meta-Analysis of Cognitive Functioning in Breast Cancer Survivors Previously Treated With Standard-Dose Chemotherapy

(2012) Heather S.L. Jim et al.   JOURNAL OF CLINICAL ONCOLOGY

Chemotherapy Was Not Associated With Cognitive Decline in Older Adults With Breast and Colorectal Cancer

(2012) Victoria A. Shaffer et al.   MEDICAL CARE

Cognitive effects of chemotherapy in breast cancer patients: a dose-response study

(2012) Barbara Collins et al.   PSYCHO-ONCOLOGY

Apolipoprotein E (APOE) Polymorphisms and Susceptibility to Breast Cancer: A Meta-Analysis

(2012) Mostafa Saadat   Cancer Research and Treatment

International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer

(2011) Jeffrey S Wefel et al.   LANCET ONCOLOGY

Is the apolipoprotein e genotype a biomarker for mild cognitive impairment? Findings from a nationally representative study.

(2011) Charles J. Brainerd et al.   NEUROPSYCHOLOGY

Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study

(2011) C. M. T. Schilder et al.   PSYCHO-ONCOLOGY

Visceral adiposity, insulin resistance and cancer risk

(2011) Claire L Donohoe et al.   Diabetology & Metabolic Syndrome

Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial

(2010) Kelly-Anne Phillips et al.   BREAST CANCER RESEARCH AND TREATMENT

Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study

(2010) Brenna C. McDonald et al.   BREAST CANCER RESEARCH AND TREATMENT

Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer

(2010) Jeffrey S. Wefel et al.   CANCER

Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors

(2010) Brent J. Small et al.   CANCER

The center for epidemiological studies depression scale (CES-D) is an adequate screening instrument for depressive and anxiety disorders in a very old population living in residential homes

(2010) Els Dozeman et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

The Challenge of Multiple Comorbidity for the US Health Care System

(2010) Anand K. Parekh   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer

(2010) Harold J. Burstein et al.   JOURNAL OF CLINICAL ONCOLOGY

Impact of Age, Sex, and Comorbidity on Cancer Therapy and Disease Progression

(2010) Sumanta Kumar Pal et al.   JOURNAL OF CLINICAL ONCOLOGY

Longitudinal Assessment of Cognitive Changes Associated With Adjuvant Treatment for Breast Cancer: Impact of Age and Cognitive Reserve

(2010) Tim A. Ahles et al.   JOURNAL OF CLINICAL ONCOLOGY

Neural mechanisms of ageing and cognitive decline

(2010) Nicholas A. Bishop et al.   NATURE

Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stress-mediated chemobrain

(2010) G. Joshi et al.   NEUROSCIENCE

The Attentional Function Index-a self-report cognitive measure

(2010) Bernadine Cimprich et al.   PSYCHO-ONCOLOGY

A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients

(2010) Catherine E. Jansen et al.   SUPPORTIVE CARE IN CANCER

The Alzheimerʼs Disease Centersʼ Uniform Data Set (UDS)

(2009) Sandra Weintraub et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors

(2009) C.M.T. Schilder et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Prechemotherapy alterations in brain function in women with breast cancer

(2009) Bernadine Cimprich et al.   JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY

Patterns of Comorbid Inflammatory Diseases in Frail Older Women: The Women's Health and Aging Studies I and II

(2009) S. S. Chang et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

The impact of different definitions and reference groups on the prevalence of cognitive impairment: a study in postmenopausal breast cancer patients before the start of adjuvant systemic therapy

(2009) Christina M. Schilder et al.   PSYCHO-ONCOLOGY

Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients

(2008) Kerstin Hermelink et al.   CANCER

Neurocognitive Changes in Cancer Survivors

(2008) Denise D. Correa et al.   CANCER JOURNAL

No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy

(2008) Mimi Mehlsen et al.   PSYCHO-ONCOLOGY